AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81
Published . Updated .
The average one-year price target for AEON Biopharma (NYSEAM:AEON) has been revised to $1.81 / share, up 16.39% from the prior estimate of $1.56 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitute a recommendation o
Directly affected
- AEON AEON Biopharma
Named in this report.
Indirectly affected
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for AEON Biopharma (NYSEAM:AEON) has been revised to $1.81 / share, up 16.39% from the prior estimate of $1.56 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel…
Source: Nasdaq Markets
How far AEON Biopharma (AEON) has moved since 2 Oct 2026
Since the first closing price after “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” AEON Biopharma (AEON) is -8.75%. The S&P 500 fund (SPY) is -1.08% over the same days, a -7.67% difference versus the market.
Who gains and who loses around AEON Biopharma (AEON)
Companies carried with this story
- AEON AEON Biopharma
For “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” AEON Biopharma (AEON) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names AEON BIOPHARMA INC in the headline; GA resolved that company to AEON
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81.” Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
For “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
In “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
For “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence. Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
For “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDE Ishares Lifepath Target Date 2045 Etf Usd
Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81.” Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
AEON Biopharma (AEON)
On 2 Oct 2026, “AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81” is the story that connects AEON Biopharma (AEON) to this story.
AEON Biopharma (AEON) is on the page because The reported development directly names AEON BIOPHARMA INC in the headline; GA resolved that company to AEON
Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is here too. Its reason reads: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the AEON Biopharma (AEON) price range
AEON traded between 0.23 and 0.42 across 20 sessions. The latest close on file is 0.23. BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. ITDC traded between 36.38 and 37.12 across 18 sessions. The latest close on file is 36.55.
What the saved facts support for AEON Biopharma (AEON)
46 out of 100
“AEON Biopharma Consensus Price Target Raised by 16.39% to $1.81” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.